INS and diabetes mellitus: While our data highlight the importance of the fine-tuned balance of cellular redox cycles in control of ER function and insulin biosynthesis, clinical trials using antioxidants with a primary endpoint of glucose control in diabetes (hemoglobin A1c) are limited (79–81).